Troy Cox

Board Director

Director

SomaLogic, Inc.Standard Biotools Inc.SOPHiA GENETICS SA MapLight Therapeutics, Inc.

Insider activity · 24 months1 buy0 salesCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 1 buy · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Companies

▲ Purchases (1 ops.)

€131k

▼ Sales (0 ops.)

—

Latest filing published 28 Jul 2026 for MapLight Therapeutics, Inc., €131k. Read the official filing

Filing timeline

BuySale

Troy Cox

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Troy Cox: trading record in brief

This profile gathers the share dealings of Troy Cox across 4 companies, led by Standard Biotools Inc., SomaLogic, Inc. and MapLight Therapeutics, Inc. We count 13 filings; the first trade dates from 1 September 2021 and the latest from 28 July 2026.

No open-market sale appears; the market trades are 1 purchase worth €131k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 10 share grants. 2026 to date brings 1 purchase and no sales.

The record was last updated on 28 July 2026 with an open-market purchase (€131k) in MapLight Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.